{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:10:38Z","timestamp":1791407438963,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T00:00:00Z","timestamp":1385078400000},"content-version":"vor","delay-in-days":205,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"PATH, the Swedish Research Council"},{"name":"V\u00e4stra G\u00f6taland Region ALF funds"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.vaccine.2013.03.027","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T08:15:28Z","timestamp":1364372128000},"page":"2457-2464","source":"Crossref","is-referenced-by-count":120,"title":["Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA\/I, CS3, CS5 and CS6 combined with a hybrid LT\/CT B subunit antigen, administered alone and together with dmLT adjuvant"],"prefix":"10.1016","volume":"31","author":[{"given":"J.","family":"Holmgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Carlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Svennerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.03.027_bib0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"Qadri","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0966-842X(96)10068-8","article-title":"Colonization factors of human enterotoxigenic Escherichia coli (ETEC)","volume":"4","author":"Gaastra","year":"1996","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0015","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Crossprotection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0020","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1128\/IAI.00459-07","article-title":"Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh","volume":"75","author":"Qadri","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0025","first-page":"188","article-title":"From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development","volume":"133","author":"Svennerholm","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.10.4.569","article-title":"distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli","volume":"10","author":"Wolf","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0035","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","article-title":"Prevention of travellers\u2019 diarrhoea by oral B-subunit\/whole-cell cholera vaccine","volume":"338","author":"Peltola","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0040","series-title":"New generation vaccines","first-page":"506","article-title":"Oral cholera vaccines","author":"Holmgren","year":"2010"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0264-410X(89)90228-4","article-title":"Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea","volume":"7","author":"Svennerholm","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0264-410X(97)00169-2","article-title":"Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine","volume":"16","author":"Jertborn","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/erv.12.12","article-title":"Recent progress toward an enterotoxigenic Escherichia coli vaccine","volume":"11","author":"Svennerholm","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0060","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.vaccine.2005.08.110","article-title":"Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups","volume":"24","author":"Qadri","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0065","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.vaccine.2007.12.009","article-title":"Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae","volume":"26","author":"Tobias","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0070","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1016\/j.vaccine.2010.08.047","article-title":"Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria","volume":"28","author":"Tobias","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0075","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1016\/j.vaccine.2011.09.096","article-title":"Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice","volume":"29","author":"Tobias","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0080","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/IAI.64.6.2144-2150.1996","article-title":"Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine","volume":"64","author":"Lebens","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0085","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/CVI.00538-10","article-title":"Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G\/L211A), as a safe and effective oral adjuvant","volume":"18","author":"Norton","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0090","first-page":"97","volume":"81","author":"World Health Organization (WHO)","year":"2006"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0095","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00253-012-3930-6","article-title":"Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates","volume":"93","author":"Tobias","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0180","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.vaccine.2012.12.063","article-title":"Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA\/I overexpressing bacteria and recombinantly produced LTB\/CTB hybrid protein","volume":"31","author":"Lundgren","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0105","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1016\/j.vaccine.2008.10.011","article-title":"Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae","volume":"26","author":"Nygren","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0923-2494(97)80867-X","article-title":"PERFEXT\u201d: a direct method for quantitative assessment of cytokine production in vivo at the local level","volume":"148","author":"Villavedra","year":"1997","journal-title":"Res Immunol"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/mpat.1994.1014","article-title":"Colonization factor antigens (CFAs) of enterotoxigenic Escherichia coli can prime and boost immune responses against heterologous CFAs","volume":"16","author":"Rudin","year":"1994","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0120","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1016\/j.vaccine.2007.03.034","article-title":"Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico","volume":"25","author":"Sack","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2005.12.002","article-title":"Enterotoxigenic Escherichia coli colonization factor types collected from 1997 to 2001 in US military personnel during operation Bright Star in northern Egypt","volume":"55","author":"Rockabrand","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0130","first-page":"1","article-title":"Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues","volume":"354","author":"Czerkinsky","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0135","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/IAI.66.2.514-520.1998","article-title":"Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates","volume":"66","author":"Johansson","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0140","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.vaccine.2009.10.147","article-title":"Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin","volume":"28","author":"Summerton","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0145","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/IAI.06174-11","article-title":"Broadly protective Shigella vaccine based on type III secretion apparatus proteins","volume":"80","author":"Martinez-Becerra","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0150","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/IAI.25.2.738-748.1979","article-title":"Purification and characterization of the CFA\/I antigen of enterotoxigenic Escherichia coli","volume":"25","author":"Evans","year":"1979","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0155","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1128\/JCM.35.4.867-872.1997","article-title":"Detection and characterization of the coli surface antigen 6 of enterotoxigenic Escherichia coli strains by using monoclonal antibodies","volume":"35","author":"Helander","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0160","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/infdis\/152.6.1128","article-title":"Presence of colonization factor antigens on fresh isolates of fecal Escherichia coli: a prospective study","volume":"152","author":"Gothefors","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0167-7012(95)00061-5","article-title":"Improved medium for large-scale production of recombinant cholera toxin B subunit for vaccine purposes","volume":"24","author":"Osek","year":"1995","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.coi.2011.03.009","article-title":"Defending the mucosa: adjuvant and carrier formulations for mucosal immunity","volume":"23","author":"Lawson","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2013.03.027_bib0175","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.vaccine.2005.09.024","article-title":"Intranasal immunization of BALB\/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(dl-lactide-co-glycolide) microspheres","volume":"24","author":"Byrd","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1300337X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1300337X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T12:00:47Z","timestamp":1595592047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1300337X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":35,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0264410X1300337X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}